3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Vomiting
37
Nausea
25
Neoplasms
12
Breast Neoplasms
6
Lymphoma
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Weight Loss
1
Solid Tumors
1
Sarcoma
1
Radiation Injuries
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms, Germ Cell and Embryonal
1
Nausea With Vomiting Chemotherapy-Induced
1
Melanoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Hematologic Diseases
1
Glioma
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Bevacizumab
14
Cisplatin
12
Surveys and Questionnaires
11
Gemcitabine
9
Drug Therapy
9
Standard of Care
8
Nivolumab
7
Cetuximab
7
pembrolizumab
6
S 1 (combination)
6
Cyclophosphamide
6
atezolizumab
5
Specimen Handling
5
Endoscopic Mucosal Resection
5
Educational Status
5
Docetaxel
5
Blood Specimen Collection
5
fludarabine
4
aldesleukin
4
Radiotherapy
4
Radiosurgery
4
Pemetrexed
4
IFL protocol
4
Folfox protocol
4
Everolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gastrointestinal Neoplasms
×
Palonosetron
×
Clear all
NCT03674294
2023-02-08
CINV
Sun Yat-sen University
Phase 3
Completed
248 enrolled